HopeStageGet research updates
HopeStage
hi@hopestage.com

Built by people with lived experience, between Sydney and Paris.

Back to overview

Bipolarity studies

Topics
More filters

Some studies do not list a clear city. Always confirm the location with the study team.

Some visits may still be in person. Participation depends on the study’s location and eligibility requirements.

Bipolarity

Bipolarity involves episodes of depression and periods of elevated or irritable mood, with unusually high energy and activity.

1979studies shown
Showing 157-168 of 1,979
Drug study icon
TerminatedNCT02075047

Efficacy and Safety study of Flexible Doses of Oral Ziprasidone in Children and Adolescents With Bipolarity type I

Official study title

A PHASE 3, MULTICENTER, FOUR-WEEK, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP EFFICACY AND SAFETY TRIAL OF FLEXIBLE DOSES OF ORAL ZIPRASIDONE IN CHILDREN AND ADOLESCENTS WITH BIPOLAR I DISORDER (CURRENT OR MOST RECENT EPISODE MANIC)

This study ended early.

Multiple locations, including Dothan
BipolarityMedication studyAges 10–17
Countries
United States, Ukraine
Sponsor
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
View study
Drug study icon
CompletedNCT04315792

Endoxifen for Bipolarity

What is this study about?

Researchers compared Endoxifen and placebo to find out how the approaches affected manic symptoms in people with bipolarity type I.

This study has finished and is no longer accepting participants.

In Miami
BipolarityMedication studyAges 18–65
Countries
United States
Sponsor
Jina Pharmaceuticals Inc.
View study
Other study type icon
CompletedNCT00001174

Evaluation of the Genetics of Bipolarity

Official study title

Bipolar Genetics: A Collaborative Study

This study has finished and is no longer accepting participants.

In Bethesda
BipolarityObservational studyAges 18–100
Countries
United States
Sponsor
National Institute of Mental Health (NIMH) (Government agency)
View study
Drug study icon
TerminatedNCT03768726

Safety study of flexible Doses Of Oral Ziprasidone in Bipolarity

What is this study about?

This study evaluates the safety of Ziprasidone for people with bipolarity.

This study ended early.

Multiple locations, including Orange City
BipolarityMedication studyAges 10–17
Countries
United States
Sponsor
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
View study
Other study type icon
CompletedNCT02794129

fMRI of Flight of Ideas in Bipolarity

Official study title

Functional Magnetic Resonance Imaging of Formal Thought Disorders in Bipolar Disorder

This study has finished and is no longer accepting participants.

In Reims
BipolarityInterventional studyAges 18–65
Countries
France
Sponsor
CHU de Reims
View study

Registry coverage

We gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.